In today’s recent session, 0.72 million shares of the Organogenesis Holdings Inc (NASDAQ:ORGO) have been traded, and its beta is 1.68. Most recently the company’s share price was $4.00, and it changed around $0.14 or 3.63% from the last close, which brings the market valuation of the company to $511.11M. ORGO at last check was trading at a discount to its 52-week high of $4.70, offering almost -17.5% off that amount. The share price’s 52-week low was $2.16, which indicates that the recent value has risen by an impressive 46.0% since then. We note from Organogenesis Holdings Inc’s average daily trading volume that its 10-day average is 0.8 million shares, with the 3-month average coming to 514.07K.
Organogenesis Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended ORGO as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Organogenesis Holdings Inc is expected to report earnings per share of 0.02 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Organogenesis Holdings Inc (NASDAQ:ORGO) trade information
Instantly ORGO has been showing a green trend so far today with a performance of 3.63% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.57 on recent trading dayincreased the stock’s daily price by 12.47%. The company’s shares are currently down -2.20% year-to-date, but still up 14.29% over the last five days. On the other hand, Organogenesis Holdings Inc (NASDAQ:ORGO) is 26.58% up in the 30-day period. We can see from the shorts that 9.79 million shares have been sold at a short interest cover period of 23.59 day(s).
The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 20.0% from its current value. Analyst projections state that ORGO is forecast to be at a low of $5 and a high of $5.
Organogenesis Holdings Inc (ORGO) estimates and forecasts
Organogenesis Holdings Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 44.40 percent over the past six months and at a -400.00% annual growth rate that is well below the industry average of 15.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 36.99% in revenue this quarter, and will report an increase of 283.49% in the next quarter. The year-over-year growth rate is expected to be 7.04%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 106.93M in revenue for the current quarter. 1 analysts expect Organogenesis Holdings Inc to make 114.7M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 99.65M and 109.98M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 7.31%. Forecasts for the next quarter put sales growth at 4.30%.
Organogenesis Holdings Inc earnings are expected to increase by -127.99% in 2024, but the outlook is positive 2.41% per year for the next five years.
ORGO Dividends
Organogenesis Holdings Inc’s next quarterly earnings report is expected to be released on 2024-Nov-12.
Organogenesis Holdings Inc (NASDAQ:ORGO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 40.61% of Organogenesis Holdings Inc shares, and 48.28% of them are in the hands of institutional investors. The stock currently has a share float of 81.28%. Organogenesis Holdings Inc stock is held by 152.0 institutions, with MORGAN STANLEY being the largest institutional investor. By 2024-06-30, it held 8.7789% of the shares, which is about 11.58 million shares worth $32.41 million.
SOLEUS CAPITAL MANAGEMENT, L.P., with 8.7356% or 11.52 million shares worth $32.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
